Inhibrx, Inc. (INBX) Misses Q4 EPS by 48c
Tweet
Share
E-mailGet Alerts INBX Hot Sheet
Join SI Premium – FREE
Inhibrx, Inc. (NASDAQ: INBX) reported Q4 EPS of ($2.11), $0.48 worse than the analyst estimate of ($1.63).
For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
- BioCardia (BCDA) Tops Q2 EPS by 5c
- Pelagos Insurance Capital Limited (PLGO) Misses Q2 EPS by 70c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
